Seegene, Inc. (KOSDAQ:096530)

South Korea · Delayed Price · Currency is KRW

31,250

+1,250 (4.17%)

Aug 20, 2026, 3:30 PM KST

14.05% (1Y)

Market Cap	1.42T +12.7%
Revenue (ttm)	496.13B +9.2%
Net Income	74.37B
EPS	1,632.61
Shares Out	45.56M
PE Ratio	19.14
Forward PE	15.91
Dividend	1,000.00 (3.20%)
Ex-Dividend Date	Sep 29, 2026

Volume	268,756
Open	31,200
Previous Close	30,000
Day's Range	30,150 - 31,500
52-Week Range	21,700 - 33,950
Beta	0.88
Analysts	Buy
Price Target	45,500.00 (+45.6%)
Earnings Date	Nov 11, 2026

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de... [Read more]

Industry Medical - Specialties

Sector Healthcare

Founded 2000

Employees 216

Stock Exchange KOSDAQ

Ticker Symbol 096530

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 096530 stock is "Buy." The 12-month stock price target is ₩45,500, which is an increase of 45.60% from the latest price.

Price Target

₩45,500

(45.60% upside)

Analyst Consensus: Buy

Stock Forecasts